NEWS

Categories
Uncategorized

AIQ SOLUTIONS AT J.P. MORGAN 39TH ANNUAL HEALTHCARE CONFERENCE 2021 DIGITAL

AIQ Solutions will be attending J.P. Morgan 39th Annual Healthcare Conference from January 11th through January 15th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions and our treatment response quantification and prediction technology.

Categories
Uncategorized

AIQ SOLUTIONS AT IMMUNO-ONCOLOGY 360° 2021

AIQ Solutions will be attending Immuno-Oncology 360° from February 23rd through 26th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions, and our treatment response quantification and prediction technology.

Categories
Uncategorized

AIQ SOLUTIONS AT ASCO GENITOURINARY CANCERS SYMPOSIUM 2021

AIQ Solutions will be attending ASCO Genitourinary Cancers Symposium from February 11th through 13th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions, and our treatment response quantification and prediction technology.

Categories
Uncategorized

VISIT AIQ SOLUTIONS AT 2022 ASCO GENITOURINARY CANCERS SYMPOSIUM BOOTH #36

Categories
Uncategorized

AIQ ANNOUNCES PARTNERSHIP WITH FLYWHEEL

Flywheel and AIQ Solutions recently announced a partnership to offer a data management and analysis solution to increase clinicians’ and researchers’ understanding of treatment response for complex diseases that include the largest research area of oncology. The combination of Flywheel’s cloud-scale data management and collaboration platform along with the powerful AIQ technology will provide a scalable solution for improved patient management and the overall delivery of accurate data for the therapeutic area.

Australian Privacy Policy AIQ's software has been cleared for clinical use under 510(k) K173444. For details, including the applicable Indications for Use, see: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K173444